Grantham, Mayo, Van Otterloo & Co (GMO)’s CARE.COM, INC. CRCM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CRCM Stock Details CRCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-36,500	Closed	-$721K	–	804
2019 Q1	$721K	Sell	36,500 -800	-2%	-$18K	0.01%	528
2018 Q4	$720K	Sell	37,300 -900	-2%	-$16.4K	0.01%	387
2018 Q3	$845K	Sell	38,200 -3,500	-8%	-$70.1K	0.01%	384
2018 Q2	$871K	Buy	41,700 +4,200	+11%	+$78.6K	0.01%	380
2018 Q1	$610K	Buy	37,500 +1,300	+4%	+$23.8K	﹤0.01%	454
2017 Q4	$653K	Buy	+36,200	New	+$634K	﹤0.01%	427

Other funds holding CRCM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TGM

Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CRCM Position: Q2 2019 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of CARE.COM, INC. (CRCM) in Q2 2019, closing a stake of 36,500 shares — an estimated $721K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CRCM in Q4 2017 and held it in 6 quarters. The position peaked at $871K in Q2 2018. 145 funds tracked by Wall St. Rank hold CRCM as of Q2 2019.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining CARE.COM, INC. position as of Q2 2019 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 36,500 CARE.COM, INC. shares in Q2 2019, an estimated $721K.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CARE.COM, INC. in Q4 2017 and held it in 6 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s CARE.COM, INC. position peaked at $871K in Q2 2018.
145 funds tracked by Wall St. Rank held CARE.COM, INC. as of Q2 2019.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2019, filed 13 Aug 2019.